bf/NASDAQ:CRBP_icon.jpeg

COM:CORBUSPHARMA

Corbus Pharmaceuticals Holdings, Inc.

  • Stock

Last Close

18.52

08/11 21:00

Market Cap

550.26M

Beta: -

Volume Today

260.68K

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Pharmaceuticals
  • website

    corbuspharma.com
  • ipo date

    Oct 27, 2014

Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibod...Show More

peer of

competitor of